Shares of uniQure (NASDAQ:QURE – Get Free Report) have received a consensus rating of “Buy” from the ten ratings firms that ...
We recently published a list of 12 Most Promising Growth Stocks According to Wall Street Analysts. In this article, we are going to take a look at where uniQure N.V. (NASDAQ:QURE) stands against other ...
H.C. Wainwright analyst Patrick Trucchio raised the firm’s price target on uniQure (QURE) to $70 from $25 and keeps a Buy rating on the shares.
Uniqure NV (QURE), an emerging leader in gene therapy, registered a 258% jump in its stock price in Q4 2024, closing the quarter at $17.66, up from $4.93 on September 30, 2024. QURE boasts a solid ...
and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy ... its ordinary shares at a public offering price of $17.00 per share. The aggregate gross ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results